Journal
ACS MEDICINAL CHEMISTRY LETTERS
Volume 3, Issue 12, Pages 1091-1096Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ml3003346
Keywords
Epigenetics; EZH2; H3K27me3; methyltransferase; PRC2; SAM-competitive inhibitor
Categories
Ask authors/readers for more resources
The histone H3-lysine 27 (H3K27) methyltransferase EZH2 plays a critical role in regulating gene expression, and its aberrant activity is linked to the onset and progression of cancer. As part of a drug discovery program targeting EZH2, we have identified highly potent, selective, SAM-competitive, and cell-active EZH2 inhibitors, including GSK926 (3) and GSK343 (6). These compounds are small molecule chemical tools that would be useful to further explore the biology of EZH2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available